Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-02-18 @ 10:00 AM
Study NCT ID:
NCT05557903
Status:
UNKNOWN
Last Update Posted:
2022-09-28
First Post:
2022-02-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
Sponsor:
Lanzhou Institute of Biological Products Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RD04-CD52-V01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None